Section Arrow
SBFM.NASDAQ
- Sunshine Biopharma Inc
Quotes are at least 15-min delayed:2025/02/23 06:32 EST
Last
 2.45
-0.02 (-0.81%)
Day High 
2.51 
Prev. Close
2.47 
1-M High
2.99 
Volume 
30.75K 
Bid
2.42
Ask
2.54
Day Low
2.425 
Open
2.46 
1-M Low
2.38 
Market Cap 
6.69M 
Currency USD 
P/E
%Yield -- 
10-SMA 2.5 
20-SMA 2.65 
50-SMA 2.83 
52-W High 285 
52-W Low 2.1056 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-127.90/--
Enterprise Value
7.23M
Balance Sheet
Book Value Per Share
9.24
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
24.09M
Operating Revenue Per Share
5.36
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
UPCUniverse Pharmaceuticals Inc0.2003+0.0578+40.56%-- 
TLRYTilray Brands0.9452+0.0775+8.93%-- 
CGCCanopy Growth Corp1.615+0.005+0.31%-- 
TXMDTherapeuticsMD1.291+0.281+27.82%0.39PE
TEVATeva Pharmaceutical Industries Limited16.74-0.26-1.53%-- 
Quotes are at least 15-min delayed:2025/02/23 06:32 EST
Industry overview quotes are at least 15 minutes delayed
Business Description
Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. The company is conducting a proprietary drug development program which is comprised of (i) K1.1 mRNA targeted for liver cancer, (ii) SBFM-PL4, PLpro protease inhibitor for SARS Coronavirus infections, and (iii) Adva-27a for pancreatic cancer. The company has two reportable segments: Prescription Generic Pharmaceuticals ("Generic Pharmaceuticals") and Nonprescription Over-The-Counter Products ("OTC Products"). The company generates the majority of its revenue from the Generic Pharmaceuticals segment.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.